⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Junevity to Present Breakthrough Research on siRNA Therapeutics at American Aging Association’s 2026 Annual Meeting
businesswire.com
LLY
The 'Hidden' Side Effect of Weight-Loss Drugs That Could Be Affecting Your Mouth, warns Oralieve
prnewswire.com
NVO
LLY
GLP-1 Receptor Agonist Market Projected to Reach USD 307 Billion by 2035 Driven by Expanding Metabolic Disease Burden – SNS Insider
globenewswire.com
LLY
NVO
Preclinical CRO (Target Discovery, Preclinical Optimization, IND-Enabling Safety) Market Trends and Growth Forecasts 2025-2026 & 2033 by Service, Development Stage, Indication, Model, End Use, Region
globenewswire.com
BMY
LLY
Mounting Rx Lawsuits Expose Ongoing Concerns Over FDA's Revolving Door
prnewswire.com
LLY
JNJ
MRNA
LimmaTech Biologics to be Acquired by Lilly for Next-generation Vaccines Against Common Bacterial Infections
businesswire.com
LLY
Lilly announces three acquisitions to build infectious disease portfolio USA - English USA - English
prnewswire.com
LLY
CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research
prnewswire.com
AMGN
LLY
TEVA
PFE
ABBV
A single dose of Lilly's PCSK9 base editor, VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia
prnewswire.com
LLY
FNB Harvest d'actions à revenu élevé annonce les distributions de mai 2026
businesswire.com
AMZN
MSFT
NVDA
LLY
MSTR
PLTR
TSLA
META
AMD
AVGO
COIN
COST
GOOGL
NFLX
AAPL
SOFI
BLKB
CRWD
JNJ
ORCL
ENB
SHOP
SU
TEL